Fig. 6

Establishment of the AR mouse model and assessment of the effect of GMK on its treatment. (A) Schematic diagram of the experimental design. (B) Histopathological analysis of nasal mucosa. (C) Nasal scratching/sneezing behaviour scores. (D) OVA-specific IgE levels in serum. (E) Relative expression levels of LEPT and NFIA in nasal mucosal tissues. Note: Data are expressed as mean ± standard deviation and statistical differences were determined by one-way analysis of variance (ANOVA) and Tukey’s multiple comparison test. ***p < 0.001, *p < 0.05, ###P < 0.01, #P < 0.05.